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There is no consensus about the effects of conjugated 
linoleic acid (CLA) on lipid metabolism, especially in ani-
mals fed a high-fat diet. Therefore, the objective of the 
present study was to evaluate the incorporation of CLA 
isomers into serum, liver and adipose tissue, as well as the 
oxidative stress generated in rats refed with high-fat diets 
after a 48 hour fast. Rats were refed with diets containing 
soybean oil, rich in linoleic acid [7% (Control Group - C) 
or 20% (LA Group)], CLA [CLA Group – 20% CLA mix-
ture (39.32 mole% c9,t11-CLA and 40.59 mole% t10,c12-
CLA)], soybean oil + CLA (LA+CLA Group - 15.4% soy-
bean oil and 4.6% CLA) or animal fat (AF, 20% lard). 
The CLA group showed lower weight gain and liver wei-
ght after refeeding, as well as increased serum choleste-
rol. The high dietary fat intake induced fat accumulation 
and an increase in α-tocopherol in the liver, which were 
not observed in the CLA group. Circulating α-tocopherol 
was increased in the CLA and CLA+LA groups. The hi-
gh-fat diets reduced liver catalase activity. CLA isomers 
were incorporated into serum and tissues. In this short-
term refeeding experimental model, CLA prevented he-
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REALIMENTACIÓN CON ÁCIDO LINOLEICO 
CONJUGADO AUMENTA COLESTEROL SÉRICO 
Y ALTERA EL PERFIL DE ÁCIDOS GRASOS 
DESPUÉS DE 48 HORAS DE AYUNO EN RATAS
Resumen 
No hay consenso acerca de los efectos del ácido lino-
leico conjugado (CLA) sobre el metabolismo lipídico, 
especialmente en animales alimentados con una dieta 
alta en grasa. Por lo tanto, el objetivo del presente es-
tudio fue evaluar la incorporación de isómeros de CLA 
en el suero, hígado y tejido adiposo, así como el estrés 
oxidativo generado en ratas realimentadas con dietas al-
tas en grasa después de 48 horas de ayuno. Los animales 
fueron realimentados con dietas que contenían aceite de 
soja, rico en ácido linoleico [7% (Groupo Control - C)], o 
20% (Groupo LA)], CLA [Groupo CLA - 20% de mezcla 
de CLA (39,32% moles del c9,t11-CLA y 40.59% moles 
del t10,c12-CLA)], aceite de soja + CLA (Grupo LA+-
CLA - 15.4 % de aceite de soja y 4,6% de CLA) o grasa 
animal (Grupo AF, 20% de manteca de cerdo). El grupo 
CLA tuvo menor aumento de peso y menor peso hepático 
después de la realimentación, así como aumento del co-
lesterol total em el suero. La dieta alta en grasa indujo la 
acumulación de grasa y un aumento de α-tocoferol en el 
hígado, que no se observaron en el grupo CLA. El α-to-
coferol serico fue mayor en los grupos CLA y LA+CLA. 
Las dietas altas en grasa redujeron la actividad de la ca-
talasa hepática. Isómeros de CLA fueron incorporados 
em el suero y tejidos. En este modelo de realimentación 
de corto prlazo, el CLA ha impedido la acumulación de 
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Abbreviations
CLA: conjugated linoleic acid
GSH: reduced glutathione.
HDL: high density lipoprotein cholesterol.
MUFAs: monounsaturated fatty acids.
PUFAs: polyunsaturated fatty acids.
SFAs: saturated fatty acids.
TAG: triacylglycerol.
TBARS: thiobarbituric acid-reactive species.
TNF-α: tumor necrosis factor-α.
Introduction
Conjugated linoleic acid (CLA) can be naturally 
found in ruminant meat and dairy products. Cis-9, 
trans-11 (c9, t11)-CLA is the most abundant isomer in 
these sources1. Several foods fortified with synthetic 
CLA might also display functional properties. These 
products contain equimolecular proportions of c9, t11-
CLA and t10, c12-CLA isomers.
The use of CLA supplements have shown potential 
beneficial effects, such as the ability to inhibit carci-
nogenesis, to decrease the risk of mammary cancer 
by 50%2, to reduce atherosclerosis3 and diabetes risk4, 
and to decrease body fat accumulation in humans and 
animals5,6.
Treatment with a 50:50 mixture of c9, t11-CLA and 
t10, c12-CLA isomers is able to generate a small in-
crease in fat-free mass in humans7 and also body fat re-
duction in overweight or obese individuals consuming 
CLA8. CLA intake has promoted lower body weight 
gain and lower white fat pad weight in male rats fed a 
high-fat diet9, and also a decrease in fat mass and an 
increase in lean mass in C57Bl/6J female mice10.
Prolonged fasting causes metabolic and hormonal 
changes related to lipid metabolism, triggers lipolysis 
and the release of free fatty acids from adipose tissue 
into the bloodstream, supplying fatty acids for hepatic 
uptake11. This process is necessary for blood glucose 
maintenance. The expression of enzymes participating 
in fatty acid oxidation are increased under fasting con-
ditions12, whereas the activity of enzymes involved in 
lipogenesis are decreased13.
Also, fasting is able to induce an increased expres-
sion of PPAR-α and β-oxidation genes activated by 
this transcription factor in healthy men13. This situa-
tion also results in rapid uptake and use of nutrients, in 
addition to lower glucose availability and the utiliza-
tion of fat as the main energy substrate. 
 Refeeding with a carbohydrate-rich diet after a 48 
hour fast causes hepatic steatosis in Wistar rats, with 
an increase in liver volume14. Likewise, rats refed with 
high-fat diet after a 24 hour fast had an increase in 
serum and hepatic triacylglycerols (TAG)15, and after 
48 hour of fasting also exhibited an increase in oxida-
tive stress markers16.
A supply of CLA can modify the energy metabo-
lism of mice, increase the energy expenditure and 
reduce the body lipid reserves without changing diet 
consumption17. The offer of CLA to rodents after 
prolonged periods of fasting has not been previously 
described. Therefore, refeeding with a high-fat diet 
containing CLA represents a valuable model to study 
the metabolic effects of these isomers in a context of 
increased nutrient uptake and consumption.
Most studies have offered limited doses of CLA 
to animals, trying to reproduce human consumption. 
Thus, there is little information about the effect of high 
doses of CLA on isomer incorporation into the liver 
and adipose tissue or about the transport of these fatty 
acids in large quantities in the postprandial state.
Therefore, the objective of the present study was 
to analyze the changes in lipid metabolism by deter-
mining the incorporation of the main CLA isomers 
commercially available into serum, liver and adipose 
tissue, as well as their potential negative effects in rats 
refed with high-fat diets after 48 hours of fasting.
Materials and Methods
Chemicals
Standard and biochemical reagents were obtained 
from Sigma Chemical Co. (St. Louis, MO, USA). 
Chromatography grade chemicals were used for fatty 
acid (FA) quantification and chemical of ACS purity 
for other procedures. H2O2 was purchased from Merck 
& Co, Inc. (São Paulo, SP, Brazil).
Diets
All diets were based on the American Institute of 
Nutrition Ad Hoc Committee recommendation (AIN-
93G)18. Five different diets were freshly prepared for 
this experiment: the control (C) diet contained 20% 
casein as the protein source and 7% soybean oil (20% 
energy) as the dietary fat source, 5% fiber, 3.5% mi-
neral mix (Premix Mineral AIN-93 G, Rhoster Ltda, 
Araçoiaba da Serra, Brazil), 1% vitamin mix (Mix Vi-
tamínico AIN-93, Rhoster Ltda, Araçoiaba da Serra, 
Brazil), 0.3% L-cystine, 0.25% choline, and 0.002% 
as di-tert-butyl methyl phenol. High-fat diets were 
prepared by replacing carbohydrate with fat (38.5% 
energy as fat) while keeping the other components. 
The linoleic acid (LA) diet contained 20% soybean 
oil, in which 59% of the FA were LA. The conjugated 
linoleic acid (CLA) diet contained 20% Tonalin® CLA 
(Illertissen, Germany), a dietary CLA supplement. The 
linoleic acid plus conjugated linoleic acid (LA+CLA) 
diet contained 15.4% soybean oil and 4.6% Tonalin® 
CLA. The animal fat (AF) diet was prepared using 
20% lard. 
Tonalin® CLA (Cognis Corporation, La Grange, Illi-
nois, USA) is a dietary CLA supplement commercially 
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available for human consumption. It is composed of an 
equimolecular mixture of c9,t11-CLA (39.32 mole%) 
and t10,c12-CLA (40.59 mole%) as the main sources 
of isomeric fatty acids. 
The quantity of CLA offered to the LA+CLA group 
(4.6%) was chosen in order to determine the use of 
these isomers as a food supplement, considering that 
doses offered to humans in clinical studies range from 
1.3 to 5.8 g/day7. The offer of 20% Tonalin® to the 
CLA group provided about 16 g CLA per 100 g diet. 
The objective of the offer of this large quantity was to 
analyze whether a high dose of CLA would be harmful 
to rats starved for a long time.
The FA composition of lipid sources as methyl es-
ters was determined by gas chromatography using the 
procedure indicated below. The soybean oil presented 
59.03 moles% as 18:2n-6, 23.47 moles% as 18:1n-
9, 13.42 as 16:0. The CLA offered 39.32 moles% as 
c9,t11-CLA, 40.59 moles% as t10,c12-CLA and 15.16 
moles% as 18:1n-9. The lard used presented 42.33 
moles% as 18:1n-9, 26.40 moles% as 16:0, and 16.27 
moles% as 18:2n-6.
Animals 
Newly weaned male Wistar rats weighing approxi-
mately 160 g were obtained from the animal facilities 
of the Faculty of Medicine of Ribeirão Preto – Univer-
sity of São Paulo. Before the beginning of the study, 
there was a 7 day acclimatization period, during which 
all rats were given free access to the standard diet and 
water. The animals were kept in individual cages on 
a 12 h light–dark cycle at 22ºC and fed standard rat 
chow. The study was approved by the Animal Re-
search Committee of the Faculty of Medicine of Ri-
beirão Preto – University of São Paulo, SP, Brazil. The 
animals were randomly divided into five groups of 8 
animals each. After a 48 h fast, rats were refed for 24 
hours with the C, LA, CLA, LA+CLA or AF diets in 
order to investigate the effects of different FA during a 
short-term refeeding period.
Next, the animals were sacrificed under anesthesia 
(1+100 mg of azepromazine and ketamine/kg b.w., 
respectively) immediately after refeeding, and blood 
and tissues (liver, adipose tissue and gastrocnemius 
muscle) were collected. All tissues were weighed and 
immediately immersed in liquid nitrogen for future 
analysis.
Biochemical Analysis
Analysis of parameters related to lipid metabolism
Total fat content was quantified in liver and muscle 
by the method of Bligh and Dyer19, using 500 mg li-
ver and 1 g muscle. For analysis of the FA profile in 
liver, adipose tissue and serum, lipids were extracted 
by the same method19 and methylated with potassium 
methoxide. We used 500 mg of liver, 250 mg of adipo-
se tissue and 0.8 ml of serum. The FA determination as 
methyl esters was carried out by gas chromatography 
(Shimadzu 2014 chromatograph equipped with a fla-
me ionization detector) using an SP-Sil 88 capillary 
column (Varian, Darmstadt, Germany) (100 m, 0.25 
mm ID, film thickness 0.20 mm). The temperature of 
both the injector and the detector was 250°C. Nitrogen 
was used as carrier gas. Injections were performed in 
the split mode. Fatty acid methyl esters were identified 
according to retention time using commercial stan-
dards (AccuStandard, New Haven, USA and Sigma, 
St. Louis MO, USA). The chromatographic data were 
processd using the GC Solutions software.
Total serum cholesterol, high density lipoprotein 
cholesterol (HDL-C) and TAG levels were determi-
ned using commercial kits (Diagnostic Labtest ® SA, 
Brazil, TAG ref. n° 87-2/100, cholesterol ref. n° 76, 
and HDL-C ref. n° 13; and SB Laboratory, Santa Fe, 
Argentina). The same procedure was applied for to-
tal cholesterol and TAG from tissues prior to liver and 
muscle fat extraction. The extracted fat was dissolved 
in 1 ml of isopropanol and then processed according to 
the kit protocol. 
Analysis of antioxidants and oxidative stress parameters
Hepatic α-tocopherol was determined by HPLC 
(LC-20A, Shimadzu ®) as described by Arnaud et 
al.20, using a C-18 (Shimpack CLC-ODS 4.6 x 25 cm) 
column. Total reduced glutathione in liver was deter-
mined by the method of Sedlack and Lindsay21. Liver 
catalase activity was assessed according to the techni-
que proposed by Aebi22and was expressed as U (mol/
min)/mg protein. Lipid peroxidation was determined 
based on thiobarbituric acid-reactive species (TBARS) 
according to the method proposed by Mihara and 
Uchiyama23.
Serum analysis
Aspartate aminotransferase (AST) and alanine ami-
notransferase (ALT) activities were determined using 
commercial kits (Diagnostic Labtest ® SA, Brazil, 
AST ref. n° 109 and ALT n° 108). Serum tumor necro-
sis factor-α (TNF-a) was determined using an enzy-
me-immunoassay kit (BD Biosciences, San Jose, CA, 
USA, catalog n° 560479). Glucose levels were deter-
mined using a commercial kit (SB Laboratory, Santa 
Fe, Argentine).
Statistical analysis
Values were expressed as mean ± standard error of 
the mean of six animals per group. Statistical diffe-
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rence between groups was established by ANOVA fo-
llowed by the Tukey test. In all analyses, the level of 
significance was set at P <0.05.
Results
Table I shows the general and biochemical parame-
ters of each group. There were no significant differen-
ces in body weight before fasting or after refeeding. 
Weight gain was lower in the CLA group compared to 
LA, LA+CLA and AF (P <0.01 for LA and P <0.05 for 
LA and CLA + AF). The group refed with the CLA-
rich diet had lower liver weight compared to the other 
groups (P <0.001). In addition, the percentage of li-
ver weight relative to body weight was lower in the 
CLA group compared to the other (P <0.001). No di-
fferences in adipose tissue weight were found between 
groups.
Liver fat content was increased by the high dietary 
fat intake (LA vs C group, P <0.05), but was preven-
ted by CLA. Serum cholesterol level was higher in the 
CLA group compared to the other groups (C, LA and 
LA+CLA, P <0.01 for AF and P <0.05). The other pa-
rameters determined in serum (HDL-C and glucose) 
remained unchanged.
There was no significant difference in serum transa-
minase or TNF-a between groups. With respect to the 
antioxidant and oxidative stress parameters, the high 
dietary fat intake induced accumulation of α-toco-
pherol in liver (LA, LA+CLA and AF vs C, P <0.01), 
which did not occur in the CLA Group. Regarding 
serum α-tocopherol, the CLA group showed the hi-
ghest values compared to the other groups (P <0.001), 
followed by the LA+CLA group (P <0.001 vs C, LA 
and AF groups). Liver catalase activity was reduced 
by the high-fat diet intake, which did not occur in the 
presence of CLA (P <0.01 vs C for CLA and LA+-
CLA). Hepatic GSH and TBARS content did not differ 
between the refeeding protocols. 
Figure 1 shows the values of TAG and total choles-
terol in liver and muscle. The AF Group had a higher 
liver TAG content than the C, LA and CLA groups (P 
<0.05 for LA and C, P <0.001 for CLA). Muscle TAG 
content was higher in the AF group compared to the 
LA+CLA group (P <0.05). Cholesterol content in li-
ver or in gastrocnemius muscle was not affected by the 
dietary treatments.
The serum FA panel (Table II) reflected the FA 
profile from the diet sources. As expected, the CLA 
group showed a higher percentage of the c9, t11-CLA 
and t10,c12-CLA isomers than the LA+CLA group (P 
<0.001 for both). 
Regarding the liver FA composition, presented in 
Table III, the CLA group showed low amounts of satu-
rated FA related to the decreased palmitic acid (16:0) 
content. 
The sum of monounsaturated fatty acids (MUFAs) 
was higher in the AF group compared to the others (P 
<0.01 vs C and P <0.001 vs LA, CLA and CLA + LA); 
the LA, LA+CLA and CLA groups showed lower va-
lues than C (P <0.05 for LA, P <0.01 for CLA and P 
<0.05 for LA+CLA). Palmitoleic acid (16:1) showed 
the lowest average in the LA, CLA and LA+CLA 
groups compared with the C group (P <0.001 for LA, 
LA+CLA and CLA vs C). Oleic acid (18:1) was hi-
gher in the AF group compared to the other groups (P 
<0.001) and lower in the CLA Group than in the C 
Group (P <0.05). 
The sum of polyunsaturated fatty acids (PUFAs) 
was higher in the CLA group compared to the C group 
(CLAxC, P <0.001), LA (CLAxLA, P <0.05) and AF 
(CLAxAF, P <0.001), higher in LA+CLA and LA 
compared with C Group (LA+CLAxC and LAxC, 






















Fig. 1.—Triacylglycerol and 
cholesterol content in liver 
and gastrocnemius muscle. 
a,bBars of the same color and 
with different letters were 
significantly different for li-
ver; a’,b’bars of the same co-
lor and with different letters 
were significantly different 
for gastrocnemius muscle (P 
<0.05, ANOVA followed by 
the Tukey post-test). TAG – 
triacylglycerols; C – Control 
group; LA – high linoleic 
acid; CLA – high conjuga-
ted linoleic acid; LA+CLA - 
high linoleic acid plus CLA; 
AF - high animal fat.
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P<0.001 for both) and AF group (LA+CLAxAF and 
LAxAF P<0.001 for both) and lower in the AF group 
compared to the C Group (P<0.05). Linoleic acid 
(18:2n6) was higher in the LA and LA+CLA groups 
compared to the C group (LAxC and LA+CLAxC, P 
<0.01 for both), CLA (LAxCLA and LA+CLAxCLA, 
P <0.001 for both) and AF (LAxAF and LA+CLAxAF, 
P <0.001 for both); and CLA Group had a lower mean 
than the C Group (P <0.05). The content of 18:3n-3 
was reduced in the CLA and AF groups vs C group. 
Arachidonic acid (20:4n-6) levels were higher in the 
CLA group and lower in the AF group. As expected, 
the c9,t11-CLA and t10,c12-CLA isomers were higher 
in the CLA group compared to the LA+CLA group (P 
<0.001 for both).
The 16:1/ 16:0 and 18:1/ 18:0 ratios allow us to 
analyze the conversion of the palmitic and stearic sa-
turated fatty acids (SFAs) to the oleic and palmitoleic 
monounsaturated fatty acids (MUFAs) by the enzyme 
Δ9 desaturase. The 16:1/ 16:0 ratio was lower in the 
LA, CLA, LA+CLA and AF groups compared to the 
C Group (P <0.001). The 18:1/ 18:0 ratio was also re-
duced in the C, LA, CLA and LA+CLA groups vs AF 
group (P <0.05). 
The 20:4n-6 / 18:2n-6 ratios are used to evaluate 
the conversion rate by elongases and desaturases re-
garding n-6 FA, and the 22:6n-3 /18:3n-3, ratios are 
used to track the conversion of n-3 FA. The CLA group 
showed the highest 20:4n-6/18:2n-6 and 22:6n-3 
/18:3n-3 ratios compared to the other groups (P <0.05).
In epididymal adipose tissue (Table IV), the sum of 
SFAs was reduced in the CLA Group, consequent to 
the reduction of palmitic acid (16:0). In addition, the 
sum of MUFAs was higher in the AF group due to the 
elevated content of oleic acid (18:1) and cis-monoe-
noic acid (20:1). The sum of PUFAs was higher in the 
LA and LA+CLA groups compared to the C group (P 
<0.05), and the AF group had the lowest values com-
pared to the C group (P <0.01). Linoleic and linolenic 
acid content was reduced in the CLA and AF groups. 
The c9,t11-CLA and t10,c12-CLA isomers were hi-
gher in the CLA Group compared to the LA+CLA 
group (P <0.05 for both).
Discussion
The liver fat content was increased by the high die-
tary fat intake, a fact that was not observed in the CLA 
group. Although the effects of CLA on liver metabo-
lism are controversial, especially regarding the increa-
se of liver size and fat accumulation, in the present 
study the supply of CLA after a prolonged fast did not 
cause hepatic abnormalities such as fatty liver disease. 
The offer of large quantities of soybean oil (LA and 
LA+CLA Groups) led to an increase in hepatic fat 
which was not saw in the CLA group. In adult male 
Wistar rats fed a high-fat diet with 20% lard and 10% 
Table II 
Serum fatty acid composition (mole%) as methyl esters
C LA CLA LA+CLA AF
14:00 0.87±0.17a,b 0.82±0.23a,b 0.47±0.04a 0.57±0.09a,b 1.19±0.21b
16:00 30.01±2.75a,b,c 26.98±2.46a,b,c 18.71±0.84a 24.47±1.63ª,c 33.95±2.45b
18:00 8.16±0.71 9.61±1.00 11.75±0.58 11.40±1.58 11.31±0.78
SFA 39.04±2.96ª,b 37.44±2.71ª,b 30.93±0.99a 36.44±3.15ª,b 46.49±2.27b
16:1n-9 0.26±0.08 0.12±0.08 0.18±0.09 0.03±0.03 0.62±0.34
18:1n- 9 10.88±1.41a 10.40±1.09a 13.60±0.26a 11.10±1.90a 18.58±1.78b
18:1n-7 1.27±0.16 1.10±0.16 1.21±0.14 1.05±0.18 1.26±0.38
MUFAs 12.83±1.55a 11.63±1.23a 15.04±0.43a,b 12.17±2.01a 20.64±2.44b
18:2n-6 37.14±1.51a 42.06±1.69b 9.43±1.06c 36.51±0.98ª 22.24±0.97d
18:3n-3 1.43±0.57 1.40±0.56 0.34±0.09 1.27±0.45 0.13±0.07
c9,t11-CLA n.d. n.d. 16.70±0.75a 2.94±0.74b n.d.
t10,c12-CLA n.d. n.d. 17.16±1.59a 3.29±0.51b n.d.
20:4n-6 8.56±1.29 7.18±1.33 8.27±0.78 6.80±1.14 9.49±0.68
22:6n-3 0.47±0.23 0.08±0.08 0.93±0.25 0.46±0.15 0.37±0.19
PUFAs 48.07±1.70a 50.86±1.63a 54.03±0.80a 51.39±1.23a 32.74±0.90b
Minor/unknown 2.18 0.72 1.33 0.35 0.13
a.b,cValues followed by different letters on the same line differed significantly (P <0.05, ANOVA followed by the Tukey post-test). FA - fatty acid, 
SFAs - saturated FA, MUFAs - monounsaturated FA, PUFAs - polyunsaturated FA; C – Control group; LA – high linoleic acid; CLA – high 
conjugated linoleic acid; LA+CLA - high linoleic acid plus conjugated linoleic acid; AF - high animal fat.
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soybean oil for 4 weeks followed by a low-fat diet 
(6.5%) with 1.5% CLA (39.2% c9,t11-CLA and 38.5% 
t10,c12-CLA), there was a reduction in the liver TAG 
content and an increased expression of genes related 
to lipid oxidation, peroxisome proliferator-activated 
receptor-α and acetyl-CoA oxidase in the CLA-fed 
group24. CLA down regulates the expression of Δ9 des-
aturase and fatty acid synthase (FAS), enzymes that 
catalyze rate-limiting steps in lipogenesis24. 
In addition, the AF group showed the greatest accu-
mulation of liver and muscle TAG. According to San-
chez et al.15, a 24 hour fast followed by refeeding with 
a diet containing 65.2% fat (bacon) causes increased 
liver TAG accumulation, higher serum triglycerides 
levels and increased free FA levels in rats15. In the pre-
sent study, the large supply of dietary FA and the pos-
sible higher amount of free FA secreted probably indu-
ced TAG accumulation in the liver of the AF Group.
Refeeding rats with a diet containing the c9,t11-
CLA and t10,c12-CLA isomers as the lipid source 
resulted in increased serum cholesterol levels with no 
HDL-C change. Bissonauth et al.25 found an increase 
in low-density lipoprotein cholesterol in hamsters fed 
the t10,c12-CLA isomer, while Navarro et al.26 repor-
ted no difference in serum total cholesterol of hamsters 
fed an atherogenic diet supplemented with 0.5% or 1% 
of the t10,c12-CLA isomer. However, a decrease of li-
ver cholesterol content was found in these animals and 
when the fractions were analyzed, there was a decrease 
of esterified cholesterol percentage25. 
The increase in total serum cholesterol associated 
with a tendency to increase serum TAG (~57% more 
compared to the C Group) without a concomitant in-
crease in total liver cholesterol may indicate that CLA 
enhanced the hepatic secretion of cholesteryl ester and 
cholesterol. CLA supply has been reported to increase 
the expression of HMG-CoA reductase, responsible 
for the synthesis of endogenous cholesterol27. Large 
Table III 
Liver fatty acid composition (mole%) as methyl esters
C LA CLA LA+CLA AF
14:00 0.44±0.04a 0.26±0.01b 0.32±0.04b 0.26±0.02b,c 0.40±0.04ª,b
16:00 31.02±1.28a 24.48±0.77b 19.08±0.78c 24.33±0.54b 29.18±0.76a
18:00 12.94±0.99a 17.21±1.22b,c 19.61±0.71c 16.78±1.04a,b,c 12.59±1.18ª,b
24:00:00 0.32±0.02ª,b 0.36±0.02a 0.32±0.02ª,b 0.27±0.01b 0.35±0.03ª,b
SFAs 44.73±0.51a 42.32±0.87a,b 39.32±0.94b 41.63±0.84a,b 42.51±0.46ª
16:01 3.06±0.44a 0.47±0.07b,c 0.26±0.04b 0.26±0.04b 1.49±0.28c
18:1n-9c 14.72±1.50a 10.56±1.18ª,b 7.51±0.30b 10.75±0.96a,b 25.25±2.40c
20:1n-9 0.15±0.01a 0.15±0.02a 0.19±0.04a 0.15±0.01a 0.33±0.04b
24:01:00 0.67±0.04a,b 0.63±0.08a,b 0.58±0.05a,b 0.45±0.05a 0.93±0.22b
MUFAs 18.64±1.92a 11.84±1.19b 8.59±0.29b 11.61±0.94b 28.01±2.56c
18:2n6c 16.10±0.95a 22.08±1.26b 11.08±0.84c 22.15±0.77b 13.18±0.63ª,c
c9,t11-CLA n.d. n.d. 8.16±1.70a 2.59±0.34b n.d.
t10,c12-CLA n.d. n.d. 6.91±1.06a 1.28±0.12b n.d.
18:3n-3 0.33±0.04a 0.61±0.06b 0.13±0.02a 0.64±0.08b 0.14±0.02a
20:3n-3 0.75±0.06ª 0.52±0.03b 0.45±0.04b 0.47±0.02b 0.59±0.06b
20:4n-6 14.45±1.24a,b 16.66±1.23a,b 18.49±0.95a 14.40±0.99a,b 11.95±1.24b
22:6n-3 5.00±0.46a,b 5.98±0.46a 6.88±0.52a 5.22±0.40a,b 3.61±0.57b
PUFAs 36.63±2.23a 45.84±0.65b 52.09±0.71c 46.75±0.58b,c 29.48±2.14d
16:1/16:0 0.096±0.011a 0.019±0.002b 0.013±0.002b 0.010±0.001b 0.050±0.008c
18:1n-9/18:0 1.228±0.197a 0.676±0.128a 0.387±0.029a 0.678±0.101a 2.166±0.427b
20:4n-6/18:2n-6c 0.909±0.083a 0.792±0.097a 1.684±0.058b 0.663±0.067a 0.906±0.084a
22:6n-3/18:3n-3 18.58±4.72ª,b 11.14±1.79ª,b 55.18±5.86c 9.39±1.78b 27.18±5.38ª
Minor/unknown 1.64 1.64 1.31 1.48 1.42
a.b,cValues followed by different letters on the same line differed significantly (P <0.05, ANOVA followed by the Tukey post-test). FA - fatty acid, 
SFAs - saturated FA, MUFAs - monounsaturated FA, PUFAs - polyunsaturated FA; C – Control group; LA – high linoleic acid; CLA – high 
conjugated linoleic acid; LA+CLA - high linoleic acid plus conjugated linoleic acid; AF - high animal fat.
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quantities of FA rise the hepatic secretion of very-low 
density lipoprotein (VLDL), which transports TAG 
and cholesterol28.
It has been reported that prolonged fasting causes a 
reduction of liver mass12,15. After fasting, the animals 
refed with CLA showed a lower liver weight. Never-
theless, this fact does not seem to be linked to liver in-
jury, since there were no differences in transaminases, 
hepatic TBARS or TNF-a. 
The liver a-tocopherol content was enlarged in the 
AF, LA and LA+CLA groups, a results that seems to 
be due to fat accumulation in liver. However, the CLA 
Group showed the highest serum a-tocopherol levels, 
which confirms the hypothesis of augmented secretion 
of VLDL by the liver, since this lipoprotein also trans-
ports vitamin E29. Furthermore, a-tocopherol transfer 
protein is reported to be increased by the ingestion of 
CLA30. 
The low liver catalase activity observed in both 
CLA-fed groups suggests that the supply of c9,t11-
CLA and t10,c12-CLA isomers led to a lower forma-
tion of H2O2 with a consequent decrease in activity of 
this enzyme. In agreement with our results, Cantwell 
et al.31 reported that catalase activity was reduced in 
cultured hepatocytes exposed to large amounts of CLA 
(20 ppm). In addition, CLA supplementation is known 
to inhibit PPAR-g expression32 which is directly rela-
ted to catalase activity33. 
In this animal model, hepatic GSH concentration 
was not changed by any dietary treatment. This fact 
disagrees with other studies5,34, which suggest an in-
creased synthesis of GSH resulting from CLA con-
sumption. The short-term refeeding may be related to 
the lack of changes observed. 
The serum FA profile reflects the type of diet consu-
med. The highest concentration of CLA appears to be 
Table IV 
Epididymal adipose tissue FA composition (mole%) as methyl esters
C LA CLA LA+CLA AF
10:00 0.47±0.09 0.63±0.07 0.90±0.22 0.64±0.25 0.63±0.11
12:00 0.94±0.18 1.25±0.13 1.76±0.41 1.28±0.46 1.17±0.21
14:00 2.20±0.17 2.33±0.18 2.71±0.27 2.29±0.35 2.45±0.17
16:00 25.86±0.48ª,b 23.85±0.65b 20.19±0.88c 22.43±0.45c 26.41±0.29ª
17:00 0.25±0.01 0.25±0.01 0.29±0.07 0.26±0.03 0.32±0.01
18:00 4.29±0.17a 4.46±0.25a 4.59±0.07a 4.78±0.28a 5.76±0.30b
24:00:00 0.11±0.01 0.11±0.01 0.19±0.07 0.11±0.03 0.15±0.01
SFAs 33.40±0.56a 32.00±0.70a,b 29.46±1.05b 30.89±0.82a,b 36.03±0.42c
16:01 4.01±0.30 2.93±0.44 2.96±0.37 2.63±0.47 3.45±0.18
18:1n-9c 28.20±0.46a 27.82±0.63a 28.12±0.79a 26.70±0.41a 32.39±0.37b
20:1n-9 0.23±0.02a 0.22±0.02a 0.32±0.03a,b 0.24±0.02a 0.35±0.03b
MUFAs 32.45±0.57a 30.97±0.99a 31.43±1.08a 29.57±0.83a 36.19±0.35b
18:2n-6c 31.89±0.72a 34.79±1.22a 27.90±0.98b 32.56±0.46a 26.52±0.48b
18:3n-6 0.12±0.02 0.19±0.06 0.40±0.23 0.10±0.02 0.25±0.12
18:3n-3 2.04±0.06a 1.16±0.22a 1.16±0.22b 2.18±0.06a 1.12±0.12b
c9,t11-CLA n.d. n.d. 5.61±1.29ª 2.56±0.38b n.d.
t10,c12-CLA n.d. n.d. 4.88±1.08a 2.29±0.35b n.d.
20:4n-6 0.68±0.05 0.60±0.04 0.47±0.10 0.66±0.05 0.68±0.04
20:5n-3 0.02±0.002 0.03±0.01 0.09±0.03 0.03±0.01 0.02±0.001
22:6n-3 0.09±0.01 0.13±0.01 0.12±0.02 0.18±0.03 0.12±0.01
PUFAs 34.84±0.75a 38.03±1.45a,b 40.61±1.73b 40.56±0.94b 28.72±0.53c
Minor/unknown 0.59 0.60 0.68 0.73 0.76
a.b,cValues followed by different letters on the same line differed significantly (P <0.05, ANOVA followed by the Tukey post-test). FA - fatty acid, 
SFAs - saturated FA, MUFAs - monounsaturated FA, PUFAs - polyunsaturated FA; C – Control group; LA – high linoleic acid; CLA – high 
conjugated linoleic acid; LA+CLA - high linoleic acid plus conjugated linoleic acid; AF - high animal fat.
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dose-dependent and seems to occur similar incorpora-
tion of the isomers into cholesterol esters and phospha-
tidylcholine35.
Regarding the FA composition of the liver, the CLA 
group showed a low saturated FA content, related to 
the decreased content of palmitic acid. There was also 
an increased stearic acid content in this group. Con-
cerning the MUFAs, oleic acid concentration was re-
duced in the CLA group although it was present in the 
diet. Sébédio et al.36 found decreased hepatic oleic acid 
and increased stearic acid in rats fed only the isomer 
t10,c12-CLA. Several authors have reported inhibition 
of Δ9 desaturase activity by CLA37,38 which was also 
observed in our study, since the CLA group had the 
lowest 18:1/18:0 ratio. The decrease in Δ9 desaturase 
activity has been reported to be related to a higher se-
cretion of VLDL by the liver and decreased liver TAG 
content36.
As expected, there was a higher incorporation of 
saturated and monounsaturated FA into epididymal 
adipose tissue in the AF Group. Concerning the in-
corporation of CLA in the different tissues analyzed, 
the CLA group showed similar hepatic incorporation 
of both isomers. However, in the LA+CLA Group, the 
c9,t11-CLA level was twice higher than the t10,c12-
CLA level. This may have been related to a higher in-
corporation of c9,t11-CLA or a faster metabolic rate of 
t10,c12-CLA. In serum and epididymal adipose tissue, 
there was no difference for the isomers in the CLA and 
LA+CLA groups despite the greater amount offered to 
the CLA group. 
Refeeding with lard led to TAG and cholesterol 
accumulation in liver and gastrocnemius muscle and 
also decreased the amount of PUFAs in liver and adi-
pose tissue and enhanced hepatic α-tocopherol. The 
LA group showed elevated liver fat, liver PUFAs and 
α-tocopherol. The CLA group showed serum choles-
terol raise, with no liver fat accumulation and a reduc-
tion of hepatic catalase activity. In contrast, the LA+-
CLA Group showed the highest amount of liver fat and 
α-tocopherol, demonstrating that CLA associated with 
soybean oil in a high-fat diet did not result in major 
benefits. 
Although, in the context of this study, large amounts 
of CLA may have generated positive effects, it is not 
possible to establish the long-term consequences pro-
duced by the large incorporation of these FA isomers, 
considering that CLA plays a role in cell signaling, ac-
tivating transcriptions factors and thereby regulating 
the enzymes of lipid metabolism transcription. 
In conclusion, refeeding with high-fat diets altered 
the liver fat and α-tocopherol contents, as well as the 
serum and liver FA profile. In this acute situation, there 
was no change in adipose tissue mass or in oxidative 
stress and antioxidant response. Despite the short re-
feeding period, CLA was widely incorporated into the 
serum and tissues analyzed and some changes in FA 
composition were observed, with an increase in stea-
ric acid and a decrease in palmitic, oleic and linoleic 
acids. There was a decrease in saturated FA in the li-
ver, especially in the group refed the highest amount of 
CLA. Acutely, large CLA quantities caused an increa-
se in serum cholesterol concentration, but at the same 
time prevented fat accumulation in the liver.
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